Back to News
Withdrawal of Ranitidine
April 2, 2020
The FDA announced that it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the market immediately due to contamination with N-Nitrosodimethylamine (NDMA).